Volume 87, Issue 2 , Pages 233-239, February 2010
Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients
Abstract
The presence of white matter lesions (WML) is an important prognostic factor for the development of stroke. High-sensitivity C-reactive protein (HSCRP), which is associated with diabetes, has been flagged as a novel predictor for cerebrovascular events. This preliminary study was therefore designed to test the hypothesis that the presence of WML correlates with HSCRP and insulin resistance in type 2 diabetic patients not receiving insulin treatment.
Based on brain magnetic resonance imaging (MRI) findings, 102 type 2 diabetic patients were divided into two groups; a WML-positive group (59
±
6 years, mean
±
SD, n
=
40) and a WML-negative group (58
±
6 years, n
=
62). The level of blood glucose was assessed by fasting plasma glucose (FPG), fasting immunoreactive insulin (F-IRI), homeostasis model assessment (HOMA) index, and Hemoglobin A1c (HbA1c).
The body mass index was higher in the WML-positive group than in the WML-negative group (p
<
0.05). Plasma levels of triglycerides were higher while high-density lipoprotein cholesterol (HDL-C) was lower in the WML-positive group than in the WML-negative group (p
<
0.01 and p
<
0.005, respectively). Fasting plasma glucose (p
<
0.005), insulin concentrations (p
<
0.0001), HOMA index (p
<
0.0001), and HSCRP (<0.0001) levels were higher in the WML-positive group than in the WML-negative group. Multivariate logistic analysis revealed that WML was independently predicted by the high HSCRP and insulin resistance (p
<
0.005, p
<
0.0005, respectively).
The results of this preliminary study indicate that the presence of WML was associated with the high HSCRP and insulin resistance in these Japanese patients with type 2 diabetes mellitus; larger cohort studies are warranted to confirm these findings.
Keywords: High-sensitivity C reactive protein, Insulin resistance, White matter lesions, Type 2 diabetes mellitus
To access this article, please choose from the options below
PII: S0168-8227(09)00465-3
doi:10.1016/j.diabres.2009.10.017
© 2009 Elsevier Ireland Ltd. All rights reserved.
Volume 87, Issue 2 , Pages 233-239, February 2010
